2021 annual financial data
Ultragenyx Pharmaceutical 2021 Operating margin
Ultragenyx Pharmaceutical 2021 operating margin with verified reported values.
Direct answer
Operating margin was -108.63%.
Operating income was -381,737,000 USD and net income was -454,025,000 USD.
Operating cash flow was -338,695,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 351,406,000 USD
- Operating income
- -381,737,000 USD
- Net income
- -454,025,000 USD
- Operating cash flow
- -338,695,000 USD